AI assistant
Q/C TECHNOLOGIES, INC. — Director's Dealing 2019
Apr 2, 2019
35313_dirs_2019-04-02_1fefc902-411d-45e3-a9da-c1e423e773ac.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Akers Biosciences, Inc. (AKER)
CIK: 0001321834
Period of Report: 2019-03-29
Reporting Person: Schreiber Christopher C (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-03-29 | Restricted Stock Units | $ | A | 124827 | Acquired | Common Stock (124827) | Direct |
Footnotes
F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Akers Biosciences, Inc. (the "Company"). The Company may also elect to settle the vested RSUs for cash at its discretion.
F2: Reporting Person was granted 124,827 RSUs under the Company's 2018 Equity Incentive Plan, as amended (the "Plan"), each of which shall vest on January 1, 2020; provided that the RSUs shall vest immediately upon a Change in Control. All capitalized but undefined terms have the meanings ascribed thereto by the Plan.